1. Home
  2. RTO vs SNN Comparison

RTO vs SNN Comparison

Compare RTO & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rentokil Initial plc

RTO

Rentokil Initial plc

N/A

Current Price

$33.24

Market Cap

15.4B

ML Signal

N/A

Logo Smith & Nephew SNATS Inc.

SNN

Smith & Nephew SNATS Inc.

N/A

Current Price

$33.24

Market Cap

14.3B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RTO
SNN
Founded
1925
1856
Country
United Kingdom
United Kingdom
Employees
65632
N/A
Industry
Business Services
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.4B
14.3B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RTO
SNN
Price
$33.24
$33.24
Analyst Decision
Buy
Hold
Analyst Count
3
3
Target Price
$35.00
$36.25
AVG Volume (30 Days)
1.5M
841.2K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.66%
2.25%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$17.39
$7.19
Revenue Next Year
$6.25
$5.36
P/E Ratio
$222.16
$64.97
Revenue Growth
N/A
N/A
52 Week Low
$19.60
$23.91
52 Week High
$33.46
$38.79

Technical Indicators

Market Signals
Indicator
RTO
SNN
Relative Strength Index (RSI) 60.34 37.97
Support Level $30.95 $33.10
Resistance Level N/A $33.89
Average True Range (ATR) 0.60 0.71
MACD 0.20 -0.45
Stochastic Oscillator 95.91 14.22

Price Performance

Historical Comparison
RTO
SNN

About RTO Rentokil Initial plc

Rentokil Initial is the largest global provider of route-based pest control and commercial hygiene services, operating in 89 countries, with its largest operations in the United States following the acquisition of Terminix. The group also offers a range of specialist route-based services, including office and commercial space plant care, property care, and workwear rentals. The group serves a diverse client base of global food producers, hotel chains, industrial goods companies, restaurants, and individual residential customers.

About SNN Smith & Nephew SNATS Inc.

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Share on Social Networks: